Clinical Trials Logo

Achalasia Cardia clinical trials

View clinical trials related to Achalasia Cardia.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03784365 Recruiting - Achalasia Cardia Clinical Trials

Single-Versus Multiple-dose Antimicrobial Prophylaxis for Peroral Endoscopic Myotomy in Achalasia

SMAPP
Start date: October 1, 2018
Phase: Phase 3
Study type: Interventional

Achalasia cardia is a primary oesophageal motility disorder of unknown etiology characterized manometrically by oesophageal aperistalsis and insufficient relaxation of the lower oesophageal sphincter (LES) in response to deglutition. Causative mechanism is unknown but may be related to genetic predisposition or autoimmunity. Because of the unknown aetiology of achalasia, a curative treatment is not available. Palliative treatment options are aimed to reduce the gradient across the LES, alleviating the primary symptoms of dysphagia and regurgitation, improving esophageal emptying, and preventing the development of megaesophagus.

NCT ID: NCT02025790 Recruiting - Achalasia Cardia Clinical Trials

POEM Versus Pneumatic Dilatation in Achalasia Cardia

Start date: December 2013
Phase: N/A
Study type: Interventional

The aim of this study is to compare efficacy of POEM and pneumatic dilatation in treatment of achalasia cardia.